Published in Environ Health Perspect on August 09, 2013
The epidemiologic evidence linking prenatal and postnatal exposure to endocrine disrupting chemicals with male reproductive disorders: a systematic review and meta-analysis. Hum Reprod Update (2016) 0.95
Prenatal PCB-153 exposure and decreased birth weight: the role of gestational weight gain. Environ Health Perspect (2014) 0.92
Prenatal Phthalate, Perfluoroalkyl Acid, and Organochlorine Exposures and Term Birth Weight in Three Birth Cohorts: Multi-Pollutant Models Based on Elastic Net Regression. Environ Health Perspect (2015) 0.91
Associations of Perfluoroalkyl Substances (PFAS) with Lower Birth Weight: An Evaluation of Potential Confounding by Glomerular Filtration Rate Using a Physiologically Based Pharmacokinetic Model (PBPK). Environ Health Perspect (2015) 0.88
Prenatal exposure to endocrine disrupting chemicals in relation to thyroid hormone levels in infants - a Dutch prospective cohort study. Environ Health (2014) 0.84
Challenges and future directions to evaluating the association between prenatal exposure to endocrine disrupting chemicals and childhood obesity. Curr Epidemiol Rep (2014) 0.81
Organochlorine Compounds and Ultrasound Measurements of Fetal Growth in the INMA Cohort (Spain). Environ Health Perspect (2015) 0.77
Overview of ongoing cohort and dietary studies in the Arctic. Int J Circumpolar Health (2016) 0.75
Maternal Concentrations of Perfluoroalkyl Substances and Fetal Markers of Metabolic Function and Birth Weight. Am J Epidemiol (2017) 0.75
Maternal serum levels of perfluoroalkyl substances and organochlorines and indices of fetal growth: a Scandinavian case-cohort study. Pediatr Res (2016) 0.75
Prenatal PCB-153 Exposure and Decreased Birth Weight: Verner et al. Respond. Environ Health Perspect (2014) 0.75
CDC growth charts: United States. Adv Data (2000) 38.32
A systematic review of outcomes of maternal weight gain according to the Institute of Medicine recommendations: birthweight, fetal growth, and postpartum weight retention. Am J Obstet Gynecol (2009) 3.07
Composition of gestational weight gain impacts maternal fat retention and infant birth weight. Am J Obstet Gynecol (2003) 2.29
Association of prenatal exposure to polybrominated diphenyl ethers and infant birth weight. Am J Epidemiol (2011) 1.90
Prenatal exposure of the northern Québec Inuit infants to environmental contaminants. Environ Health Perspect (2001) 1.88
Birth weight and prenatal exposure to polychlorinated biphenyls (PCBs) and dichlorodiphenyldichloroethylene (DDE): a meta-analysis within 12 European Birth Cohorts. Environ Health Perspect (2011) 1.84
Risk of breast cancer and organochlorine exposure. Cancer Epidemiol Biomarkers Prev (2000) 1.70
Four-component model for the assessment of body composition in humans: comparison with alternative methods, and evaluation of the density and hydration of fat-free mass. Clin Sci (Lond) (1992) 1.59
Intrinsic human elimination half-lives of polychlorinated biphenyls derived from the temporal evolution of cross-sectional biomonitoring data from the United Kingdom. Environ Health Perspect (2010) 1.43
Body composition data for individuals 8 years of age and older: U.S. population, 1999-2004. Vital Health Stat 11 (2010) 1.24
Correlations among polychlorinated biphenyls, dioxins, and furans in humans. Am J Ind Med (1999) 1.20
Determinants of serum concentrations of organochlorine compounds in Swedish pregnant women: a cross-sectional study. Environ Health (2007) 1.16
Serum lipids, lipoproteins and apolipoproteins in pregnant non-diabetic patients. J Clin Pathol (1994) 1.14
Maternal levels of polychlorinated biphenyls in relation to preterm and small-for-gestational-age birth. Epidemiology (2005) 1.13
Serum lipids in young women before, during, and after pregnancy. Am J Epidemiol (1987) 1.11
Intrauterine growth and adipose tissue development. Am J Clin Nutr (1981) 1.05
Changes in serum concentrations of polychlorinated biphenyls (PCBs), hydroxylated PCB metabolites and pentachlorophenol during pregnancy. Chemosphere (2011) 1.04
Toxicokinetic modeling of persistent organic pollutant levels in blood from birth to 45 months of age in longitudinal birth cohort studies. Environ Health Perspect (2012) 1.02
Alterations of serum lipid levels and their biological relevances during and after pregnancy. Life Sci (1995) 1.01
Effects of gestational alcohol exposure on the fatty acid composition of umbilical cord serum in humans. Am J Clin Nutr (2000) 0.97
Fetal Biometry. Growth charts for practical use in fetopathology and antenatal ultrasonography. Introduction. Fetal Diagn Ther (1995) 0.95
A physiologically based pharmacokinetic model for the assessment of infant exposure to persistent organic pollutants in epidemiologic studies. Environ Health Perspect (2008) 0.92
Serum lipids and lipoproteins in human pregnancy. Clin Chim Acta (1966) 0.80
Toxicity testing in the 21st century: implications for human health risk assessment. Risk Anal (2008) 5.57
Fish intake during pregnancy and early cognitive development of offspring. Epidemiology (2004) 3.83
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol (2013) 3.00
Inhaled carbon nanotubes reach the subpleural tissue in mice. Nat Nanotechnol (2009) 2.78
Reactive oxygen species as a signal in glucose-stimulated insulin secretion. Diabetes (2007) 2.59
Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology (2007) 2.22
Anogenital distance in human male and female newborns: a descriptive, cross-sectional study. Environ Health (2004) 2.17
Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review. Environ Health Perspect (2012) 2.05
Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment. Toxicol Sci (2011) 2.03
Urinary metabolite concentrations of organophosphorous pesticides, bisphenol A, and phthalates among pregnant women in Rotterdam, the Netherlands: the Generation R study. Environ Res (2008) 2.01
Perfluorinated compounds and subfecundity in pregnant women. Epidemiology (2012) 1.98
Outcome-dependent sampling: an efficient sampling and inference procedure for studies with a continuous outcome. Epidemiology (2007) 1.92
A comprehensive statistical analysis of predicting in vivo hazard using high-throughput in vitro screening. Toxicol Sci (2012) 1.81
In utero exposure to background levels of polychlorinated biphenyls and cognitive functioning among school-age children. Am J Epidemiol (2005) 1.75
Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in Sweden. Environ Health Perspect (2006) 1.70
The National Children's Study of environmental effects on child health and development. Environ Health Perspect (2003) 1.68
ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function. Toxicol Appl Pharmacol (2009) 1.63
Prenatal exposure to 1,1-dichloro-2,2-bis (p-chlorophenyl)ethylene (p,p'-DDE) in relation to child growth. Int J Epidemiol (2006) 1.62
Use of Markov Chain Monte Carlo analysis with a physiologically-based pharmacokinetic model of methylmercury to estimate exposures in US women of childbearing age. Risk Anal (2007) 1.61
Maternal dental history, child's birth outcome and early cognitive development. Paediatr Perinat Epidemiol (2007) 1.56
Levels of metabolites of organophosphate pesticides, phthalates, and bisphenol A in pooled urine specimens from pregnant women participating in the Norwegian Mother and Child Cohort Study (MoBa). Int J Hyg Environ Health (2009) 1.51
Genomic signatures and dose-dependent transitions in nasal epithelial responses to inhaled formaldehyde in the rat. Toxicol Sci (2008) 1.51
Maternal smoking during pregnancy in relation to child overweight: follow-up to age 8 years. Int J Epidemiol (2005) 1.51
Low-level arsenic impairs glucose-stimulated insulin secretion in pancreatic beta cells: involvement of cellular adaptive response to oxidative stress. Environ Health Perspect (2010) 1.47
Organotypic liver culture models: meeting current challenges in toxicity testing. Crit Rev Toxicol (2012) 1.46
Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene. Crit Rev Toxicol (2004) 1.45
Physiological modeling of inhalation kinetics of octamethylcyclotetrasiloxane in humans during rest and exercise. Toxicol Sci (2003) 1.44
Application of biologically based computer modeling to simple or complex mixtures. Environ Health Perspect (2002) 1.42
Within-person variability in urinary bisphenol A concentrations: measurements from specimens after long-term frozen storage. Environ Res (2009) 1.40
Reliability and determinants of anogenital distance and penis dimensions in male newborns from Chiapas, Mexico. Paediatr Perinat Epidemiol (2007) 1.36
Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: a physiologically based pharmacokinetic approach. Toxicol Sci (2005) 1.35
Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys--probing the determinants of long plasma half-lives. Toxicology (2006) 1.34
Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States). Cancer Causes Control (2003) 1.32
Incorporating human dosimetry and exposure into high-throughput in vitro toxicity screening. Toxicol Sci (2010) 1.30
PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals. Toxicology (2010) 1.28
A systems biology perspective on Nrf2-mediated antioxidant response. Toxicol Appl Pharmacol (2009) 1.25
Maternal serum levels of polychlorinated biphenyls and 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE) and time to pregnancy. Am J Epidemiol (2005) 1.23
A deterministic map of Waddington's epigenetic landscape for cell fate specification. BMC Syst Biol (2011) 1.21
Prenatal exposure to low-level polychlorinated biphenyls in relation to mental and motor development at 8 months. Am J Epidemiol (2003) 1.20
Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling. J Expo Sci Environ Epidemiol (2006) 1.19
Ultrasensitive response motifs: basic amplifiers in molecular signalling networks. Open Biol (2013) 1.16
Dose-dependent transitions in Nrf2-mediated adaptive response and related stress responses to hypochlorous acid in mouse macrophages. Toxicol Appl Pharmacol (2009) 1.15
Prenatal DDT exposure in relation to anthropometric and pubertal measures in adolescent males. Environ Health Perspect (2004) 1.14
Single cell analysis of switch-like induction of CYP1A1 in liver cell lines. Toxicol Sci (2004) 1.13
Optimal Exposure Biomarkers for Nonpersistent Chemicals in Environmental Epidemiology. Environ Health Perspect (2015) 1.13
Evidence of a "clear and consistent threshold" for bladder and liver cancer in the large ED01 carcinogenicity study. Toxicol Sci (2003) 1.12
Blood mercury level and blood pressure among US women: results from the National Health and Nutrition Examination Survey 1999-2000. Environ Res (2005) 1.12
Fetal growth and prenatal exposure to bisphenol A: the generation R study. Environ Health Perspect (2012) 1.11
The need for a new toxicity testing and risk analysis paradigm to implement REACH or any other large scale testing initiative. Arch Toxicol (2007) 1.11
Perfluorinated compounds in relation to birth weight in the Norwegian Mother and Child Cohort Study. Am J Epidemiol (2012) 1.10
In utero exposure to maternal tobacco smoke and subsequent obesity, hypertension, and gestational diabetes among women in the MoBa cohort. Environ Health Perspect (2011) 1.10
Adipose deficiency of Nrf2 in ob/ob mice results in severe metabolic syndrome. Diabetes (2012) 1.10
Incorporating new technologies into toxicity testing and risk assessment: moving from 21st century vision to a data-driven framework. Toxicol Sci (2013) 1.10
New directions in toxicity testing. Annu Rev Public Health (2011) 1.09
Within-person variability in urinary phthalate metabolite concentrations: measurements from specimens after long-term frozen storage. J Expo Sci Environ Epidemiol (2009) 1.09
Polybrominated diphenyl ethers in breast milk from Uppsala County, Sweden. Environ Res (2003) 1.09
Toxicity testing in the 21 century: defining new risk assessment approaches based on perturbation of intracellular toxicity pathways. PLoS One (2011) 1.09
Induction of CYP1A1 in primary rat hepatocytes by 3,3',4,4',5-pentachlorobiphenyl: evidence for a switch circuit element. Toxicol Sci (2004) 1.08
Dose-dependent transitions in mechanisms of toxicity: case studies. Toxicol Appl Pharmacol (2004) 1.08
Long isoforms of NRF1 contribute to arsenic-induced antioxidant response in human keratinocytes. Environ Health Perspect (2010) 1.07
Characterizing uncertainty and variability in physiologically based pharmacokinetic models: state of the science and needs for research and implementation. Toxicol Sci (2007) 1.07
Quantitative interpretation of human biomonitoring data. Toxicol Appl Pharmacol (2008) 1.07
Dose response relationship in anti-stress gene regulatory networks. PLoS Comput Biol (2006) 1.07
Linear low-dose extrapolation for noncancer heath effects is the exception, not the rule. Crit Rev Toxicol (2011) 1.07
Nuclear factor erythroid-derived factor 2-related factor 2 regulates transcription of CCAAT/enhancer-binding protein β during adipogenesis. Free Radic Biol Med (2011) 1.07
t4 workshop report: Pathways of Toxicity. ALTEX (2013) 1.06
Misuse of blood serum to assess exposure to bisphenol A and phthalates. Breast Cancer Res (2013) 1.06
Polychlorinated biphenyls and menstrual cycle characteristics. Epidemiology (2005) 1.04
Long-term coffee consumption in relation to fracture risk and bone mineral density in women. Am J Epidemiol (2013) 1.04
Prenatal exposure to the major DDT metabolite 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE) and growth in boys from Mexico. Environ Res (2010) 1.04
Exposure assessment and risk characterization for perfluorooctanoate in selected consumer articles. Environ Sci Technol (2005) 1.04
Use of a physiologically based pharmacokinetic model to identify exposures consistent with human biomonitoring data for chloroform. J Toxicol Environ Health A (2006) 1.03
Relative impact of incorporating pharmacokinetics on predicting in vivo hazard and mode of action from high-throughput in vitro toxicity assays. Toxicol Sci (2013) 1.03
Application of transcriptional benchmark dose values in quantitative cancer and noncancer risk assessment. Toxicol Sci (2010) 1.03
Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury. Hepatology (2010) 1.03
Prolonged inorganic arsenite exposure suppresses insulin-stimulated AKT S473 phosphorylation and glucose uptake in 3T3-L1 adipocytes: involvement of the adaptive antioxidant response. Biochem Biophys Res Commun (2011) 1.02
Meeting report: measuring endocrine-sensitive endpoints within the first years of life. Environ Health Perspect (2008) 1.02
Activation of Nrf2-mediated oxidative stress response in macrophages by hypochlorous acid. Toxicol Appl Pharmacol (2007) 1.02
In vitro to in vivo extrapolation and species response comparisons for drug-induced liver injury (DILI) using DILIsym™: a mechanistic, mathematical model of DILI. J Pharmacokinet Pharmacodyn (2012) 1.02
PCDD/F, PCB, PBDE, HBCD and chlorinated pesticides in a Swedish market basket from 2005--levels and dietary intake estimations. Chemosphere (2011) 1.01
Development of PBPK models for PFOA and PFOS for human pregnancy and lactation life stages. J Toxicol Environ Health A (2013) 1.00
A method to integrate benchmark dose estimates with genomic data to assess the functional effects of chemical exposure. Toxicol Sci (2007) 1.00
Coffee consumption and CYP1A2 genotype in relation to bone mineral density of the proximal femur in elderly men and women: a cohort study. Nutr Metab (Lond) (2010) 0.99
Analysis of manganese tracer kinetics and target tissue dosimetry in monkeys and humans with multi-route physiologically based pharmacokinetic models. Toxicol Sci (2010) 0.99
Non-monotonic dose-response relationship in steroid hormone receptor-mediated gene expression. J Mol Endocrinol (2007) 0.99
Temporal concordance between apical and transcriptional points of departure for chemical risk assessment. Toxicol Sci (2013) 0.98
Application of pharmacokinetic data to the risk assessment of inhaled manganese. Neurotoxicology (2006) 0.98
In silico toxicology: simulating interaction thresholds for human exposure to mixtures of trichloroethylene, tetrachloroethylene, and 1,1,1-trichloroethane. Environ Health Perspect (2002) 0.98
An analysis of N-acetylcysteine treatment for acetaminophen overdose using a systems model of drug-induced liver injury. J Pharmacol Exp Ther (2012) 0.98